Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 CYP1A1 | 10 | 2017 | 43 | 3.270 |
Why?
|
| Ceramides | 9 | 2023 | 41 | 3.210 |
Why?
|
| Cytochrome P-450 CYP1A2 | 7 | 2017 | 21 | 2.470 |
Why?
|
| Flavones | 4 | 2023 | 8 | 2.360 |
Why?
|
| Enzyme Inhibitors | 12 | 2014 | 396 | 2.160 |
Why?
|
| Cytochrome P-450 Enzyme System | 9 | 2023 | 82 | 1.790 |
Why?
|
| Coumarins | 4 | 2019 | 35 | 1.700 |
Why?
|
| Antineoplastic Agents | 6 | 2018 | 756 | 1.240 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 1426 | 1.100 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 8 | 2016 | 49 | 1.070 |
Why?
|
| Nicotine | 1 | 2023 | 238 | 0.800 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2019 | 1 | 0.710 |
Why?
|
| Xenobiotics | 1 | 2019 | 10 | 0.710 |
Why?
|
| Tumor Burden | 1 | 2018 | 79 | 0.660 |
Why?
|
| Anthraquinones | 1 | 2017 | 7 | 0.600 |
Why?
|
| Structure-Activity Relationship | 8 | 2015 | 376 | 0.580 |
Why?
|
| Ligands | 4 | 2017 | 317 | 0.510 |
Why?
|
| Alkynes | 2 | 2012 | 49 | 0.500 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2014 | 209 | 0.500 |
Why?
|
| Ethers | 2 | 2012 | 19 | 0.500 |
Why?
|
| Cell Line, Tumor | 7 | 2023 | 2128 | 0.490 |
Why?
|
| Drug Design | 3 | 2015 | 154 | 0.490 |
Why?
|
| Models, Molecular | 7 | 2019 | 751 | 0.480 |
Why?
|
| Humans | 30 | 2023 | 34853 | 0.460 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2023 | 16 | 0.410 |
Why?
|
| Kinetics | 6 | 2015 | 650 | 0.400 |
Why?
|
| Catalytic Domain | 5 | 2014 | 97 | 0.400 |
Why?
|
| Quantitative Structure-Activity Relationship | 3 | 2019 | 103 | 0.350 |
Why?
|
| Apoptosis | 6 | 2023 | 1317 | 0.330 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2017 | 81 | 0.330 |
Why?
|
| Phenanthrenes | 3 | 2016 | 16 | 0.280 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2018 | 30 | 0.280 |
Why?
|
| Carcinogens | 2 | 2023 | 117 | 0.250 |
Why?
|
| Fluorometry | 2 | 2014 | 15 | 0.240 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 336 | 0.240 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 242 | 0.240 |
Why?
|
| Animals | 10 | 2023 | 14307 | 0.230 |
Why?
|
| Mice | 4 | 2023 | 5668 | 0.230 |
Why?
|
| Cell Proliferation | 2 | 2023 | 1149 | 0.220 |
Why?
|
| Flavonoids | 3 | 2013 | 78 | 0.210 |
Why?
|
| Cell Survival | 4 | 2020 | 818 | 0.200 |
Why?
|
| Protein Binding | 5 | 2017 | 913 | 0.200 |
Why?
|
| Lymphoma, Primary Effusion | 1 | 2020 | 1 | 0.200 |
Why?
|
| Sphingolipids | 1 | 2020 | 13 | 0.200 |
Why?
|
| Sarcoma, Kaposi | 1 | 2020 | 20 | 0.200 |
Why?
|
| Herpesvirus 8, Human | 1 | 2020 | 25 | 0.190 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2015 | 45 | 0.190 |
Why?
|
| Government Programs | 1 | 2020 | 28 | 0.190 |
Why?
|
| Cultural Diversity | 1 | 2020 | 158 | 0.180 |
Why?
|
| Splenic Neoplasms | 1 | 2018 | 1 | 0.170 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 32 | 0.170 |
Why?
|
| Naphthalenes | 2 | 2016 | 37 | 0.160 |
Why?
|
| Oxidation-Reduction | 3 | 2016 | 407 | 0.160 |
Why?
|
| Biphenyl Compounds | 2 | 2016 | 52 | 0.160 |
Why?
|
| Adamantane | 1 | 2018 | 8 | 0.160 |
Why?
|
| Female | 6 | 2023 | 19873 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 65 | 0.160 |
Why?
|
| Binding Sites | 3 | 2014 | 597 | 0.160 |
Why?
|
| Pyrenes | 2 | 2015 | 24 | 0.160 |
Why?
|
| Mice, Nude | 1 | 2018 | 323 | 0.160 |
Why?
|
| NADP | 2 | 2014 | 24 | 0.150 |
Why?
|
| Universities | 1 | 2020 | 363 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 211 | 0.150 |
Why?
|
| Pyridines | 1 | 2018 | 113 | 0.150 |
Why?
|
| Glucosyltransferases | 2 | 2014 | 7 | 0.150 |
Why?
|
| Enzyme Assays | 1 | 2017 | 11 | 0.150 |
Why?
|
| Phenylalanine | 1 | 2017 | 20 | 0.150 |
Why?
|
| Substrate Specificity | 1 | 2017 | 186 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 82 | 0.150 |
Why?
|
| Models, Chemical | 2 | 2015 | 201 | 0.140 |
Why?
|
| Dioxanes | 1 | 2015 | 10 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2020 | 371 | 0.140 |
Why?
|
| Students | 1 | 2020 | 452 | 0.140 |
Why?
|
| Hydrocortisone | 1 | 2015 | 72 | 0.130 |
Why?
|
| Crystallography, X-Ray | 2 | 2013 | 237 | 0.130 |
Why?
|
| Liver | 1 | 2017 | 447 | 0.130 |
Why?
|
| Benzeneacetamides | 1 | 2014 | 4 | 0.120 |
Why?
|
| Ketones | 1 | 2014 | 17 | 0.120 |
Why?
|
| Ceramidases | 1 | 2013 | 1 | 0.120 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 117 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 43 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 111 | 0.110 |
Why?
|
| Quinones | 1 | 2012 | 10 | 0.110 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 196 | 0.110 |
Why?
|
| Time Factors | 1 | 2017 | 1681 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2017 | 874 | 0.100 |
Why?
|
| Environmental Pollutants | 1 | 2013 | 166 | 0.100 |
Why?
|
| Lysophospholipids | 1 | 2009 | 19 | 0.090 |
Why?
|
| Sphingosine | 1 | 2009 | 21 | 0.090 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2009 | 10 | 0.090 |
Why?
|
| Hormones | 1 | 2009 | 51 | 0.090 |
Why?
|
| Microsomes, Liver | 2 | 2008 | 69 | 0.080 |
Why?
|
| Imidazoles | 1 | 2008 | 124 | 0.080 |
Why?
|
| Cell Line | 1 | 2010 | 1289 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2013 | 1802 | 0.060 |
Why?
|
| Carbazoles | 1 | 2004 | 43 | 0.060 |
Why?
|
| Computer Simulation | 3 | 2012 | 347 | 0.060 |
Why?
|
| Neoplasms | 1 | 2013 | 1033 | 0.060 |
Why?
|
| Indoles | 1 | 2004 | 154 | 0.060 |
Why?
|
| Molecular Structure | 2 | 2016 | 467 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 43 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2020 | 143 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 77 | 0.050 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2010 | 22 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2013 | 350 | 0.050 |
Why?
|
| Income | 1 | 2020 | 135 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 480 | 0.040 |
Why?
|
| Educational Status | 1 | 2020 | 295 | 0.040 |
Why?
|
| Lactones | 1 | 1998 | 20 | 0.040 |
Why?
|
| Mycobacterium | 1 | 1998 | 15 | 0.040 |
Why?
|
| Virus Replication | 1 | 2020 | 261 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 1998 | 27 | 0.040 |
Why?
|
| Sesquiterpenes | 1 | 1998 | 30 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 220 | 0.040 |
Why?
|
| Cell Growth Processes | 1 | 2018 | 41 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 139 | 0.040 |
Why?
|
| Rats | 3 | 2012 | 3261 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 117 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 600 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2020 | 1353 | 0.040 |
Why?
|
| Steroid 21-Hydroxylase | 1 | 2015 | 1 | 0.040 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 2015 | 2 | 0.040 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Patents as Topic | 1 | 2015 | 11 | 0.030 |
Why?
|
| Lepidoptera | 1 | 2015 | 8 | 0.030 |
Why?
|
| Polycyclic Compounds | 1 | 2015 | 8 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 406 | 0.030 |
Why?
|
| Isomerism | 1 | 2014 | 62 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 150 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2013 | 22 | 0.030 |
Why?
|
| Rabbits | 1 | 2013 | 278 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2012 | 119 | 0.030 |
Why?
|
| Models, Biological | 1 | 2015 | 642 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2012 | 207 | 0.030 |
Why?
|
| United States | 1 | 2020 | 3894 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4012 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2013 | 436 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 5035 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2009 | 94 | 0.020 |
Why?
|
| Stilbenes | 1 | 2009 | 41 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 281 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 423 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 984 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 9642 | 0.020 |
Why?
|
| Male | 2 | 2020 | 18870 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 11034 | 0.020 |
Why?
|
| Chlorodiphenyl (54% Chlorine) | 1 | 2004 | 1 | 0.020 |
Why?
|
| Tryptophan | 1 | 2004 | 62 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1534 | 0.010 |
Why?
|
| Mycobacterium avium | 1 | 1998 | 3 | 0.010 |
Why?
|
| Asteraceae | 1 | 1998 | 3 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1998 | 203 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1998 | 84 | 0.010 |
Why?
|